Epidemiology and Infection, Vol. 140, No. 8 (AUGUST 2012), pp. 1343-1355 (13 pages) Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased considerably during the past ...

AB SCIEX and Dalton Pharma Services announced that they are joining forces on R&D for antibody-drug conjugate analysis capabilities. "A key challenge for developing successful antibody-drug conjugate ...

TORONTO--(BUSINESS WIRE)--AB SCIEX and Dalton Pharma Services (Dalton) announced today a research collaboration to develop Antibody-Drug Conjugate (ADC) analysis capabilities. This will include ...

Variations in conjugation chemistry conditions can lead to differences in stoichiometries and, ultimately, impact drug safety and efficacy. Therefore, there is an urgent need to measure multiple ...

Antibody–drug conjugates (ADCs) present significant analytical challenges due to their heterogeneity and complex product quality attributes. The ADC development pipeline often relies on multiple ...

Driven by the success of 14 approved antibody drug conjugates (ADCs) and a promising developmental pipeline, the field of ADCs has gained significant traction and are anticipated to capture a notable ...